Skip to main content

Davidson Michael H.'s Form 4 filing

NewAmsterdam Pharma Co N.V. (NAMS) · filed Feb 26, 2026

Accession no.
0001193125-26-078718
Filed
Feb 26, 2026
Trade date
Feb 24-26, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 3 derivative transactions. Open-market sales total $10.6M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Davidson Michael H.CIK 0001573785Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 24, 2026Ordinary SharesMOption exerciseAcquired+64,708––524,567Direct
Feb 24, 2026Ordinary SharesSSaleDisposed−61,547$36.13−$2,223,693.11463,020Direct
Feb 24, 2026Ordinary SharesSSaleDisposed−3,161$36.46−$115,250.06459,859Direct
Feb 25, 2026Ordinary SharesMOption exerciseAcquired+58,253––518,112Direct
Feb 25, 2026Ordinary SharesSSaleDisposed−46,517$35.11−$1,633,211.87471,595Direct
Feb 25, 2026Ordinary SharesSSaleDisposed−10,436$35.96−$375,278.56461,159Direct
Feb 25, 2026Ordinary SharesSSaleDisposed−1,300$36.68−$47,684459,859Direct
Feb 26, 2026Ordinary SharesMOption exerciseAcquired+183,332––643,191Direct
Feb 26, 2026Ordinary SharesSSaleDisposed−165,408$33.63−$5,562,671.04477,783Direct
Feb 26, 2026Ordinary SharesSSaleDisposed−17,924$34.44−$617,302.56174,144Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 24, 2026Ordinary SharesMOption exerciseDisposed−64,708$0.00$0924,559Direct
Feb 25, 2026Ordinary SharesMOption exerciseDisposed−58,253$0.00$0866,306Direct
Feb 26, 2026Ordinary SharesMOption exerciseDisposed−183,332$0.00$0682,974Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)